These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24796774)

  • 1. Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.
    Zedan AH; Vilholm OJ
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):193-200. PubMed ID: 24796774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.
    Frigeni B; Piatti M; Lanzani F; Alberti P; Villa P; Zanna C; Ceracchi M; Ildebrando M; Cavaletti G
    J Peripher Nerv Syst; 2011 Sep; 16(3):228-36. PubMed ID: 22003937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and treatment of polyneuropathy developed after chemotherapy].
    Kholodova NB; Sotnikov VM; Dobrovol'skaia NIu; Ponkratova IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):20-4. PubMed ID: 23739498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
    Cavaletti G; Frigeni B; Lanzani F; Mattavelli L; Susani E; Alberti P; Cortinovis D; Bidoli P
    Eur J Cancer; 2010 Feb; 46(3):479-94. PubMed ID: 20045310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
    Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB
    J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
    Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
    Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
    Beijers AJ; Jongen JL; Vreugdenhil G
    Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity of taxanes: symptoms and quality of life assessment.
    Kuroi K; Shimozuma K
    Breast Cancer; 2004; 11(1):92-9. PubMed ID: 14718800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and electromyography characteristics of chemotherapy-induced polyneuropathy].
    Kholodova NB; Ponkratova YA; Sinkin MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):59-66. PubMed ID: 29053122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
    Fontes F; Pereira S; Castro-Lopes JM; Lunet N
    Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.
    Zedan AH; Hansen TF; Fex Svenningsen A; Vilholm OJ
    Clin Colorectal Cancer; 2014 Jun; 13(2):73-80. PubMed ID: 24365057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy.
    Grim J; Ticha A; Hyspler R; Valis M; Zadak Z
    Nutrients; 2017 May; 9(6):. PubMed ID: 28587059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed oxaliplatin-induced sensorimotor polyneuropathy.
    Nardone R; Buratti T; Golaszewski S; Bratti A; Caleri F; Tezzon F; Ladurner G; Mitterer M
    Onkologie; 2009 May; 32(5):283-5. PubMed ID: 19420977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients.
    Timmins HC; Li T; Kiernan MC; Horvath LG; Goldstein D; Park SB
    J Pain; 2020; 21(1-2):44-58. PubMed ID: 31325646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organophosphate induced delayed polyneuropathy in man: an overview.
    Jokanović M; Kosanović M; Brkić D; Vukomanović P
    Clin Neurol Neurosurg; 2011 Jan; 113(1):7-10. PubMed ID: 20880629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe encephalopathy and polyneuropathy induced by dichloroacetate.
    Brandsma D; Dorlo TP; Haanen JH; Beijnen JH; Boogerd W
    J Neurol; 2010 Dec; 257(12):2099-100. PubMed ID: 20632025
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: A file-based observational study.
    Argyriou AA; Bruna J; Kalofonou F; Velasco R; Litsardopoulos P; Alemany M; Anastopoulou GG; Kalofonos HP
    J Peripher Nerv Syst; 2024 Mar; 29(1):38-46. PubMed ID: 38311337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes.
    Mahfouz FM; Li T; Joda M; Harrison M; Horvath LG; Grimison P; King T; Marx G; Goldstein D; Park SB
    Support Care Cancer; 2023 Dec; 32(1):46. PubMed ID: 38117349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.
    Smith EM; Beck SL; Cohen J
    Oncol Nurs Forum; 2008 Jan; 35(1):96-102. PubMed ID: 18192158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
    Velasco R; Bruna J
    Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.